Petros Pharmaceuticals has launched its artificial intelligence tool developed as a result of its collaboration with a multi-billion-dollar software developer. The tool is being integrated into the Company’s web app being used for patient self-screening, which it is testing in its recently launched Human Factors study.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
